Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydantoins as antitumor agents

T R Rodgers, M P LaMontagne, A Markovac

    Journal of Medicinal Chemistry
    |April 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Researchers synthesized 27 hydantoin compounds and tested their antitumor potential. The most effective agent, 5,5-bis(4-chlorophenyl)-1,3-dichlorohydantoin, showed significant activity against lymphocytic leukemia in mice.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.

    Drug metabolism and disposition: the biological fate of chemicals·1996
    Same author

    Localization of the 110 kDa receptor for laminin in brains of embryonic and postnatal mice.

    Cell and tissue research·1995
    Same author

    Antimalarials. 16. Synthesis of 2-substituted analogues of 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3- (trifluoromethyl)phenoxy]quinoline as candidate antimalarials.

    Journal of medicinal chemistry·1989
    Same author

    Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties.

    Journal of medicinal chemistry·1988
    Same author

    Antimalarials. 14. 5-(aryloxy)-4-methylprimaquine analogues. A highly effective series of blood and tissue schizonticidal agents.

    Journal of medicinal chemistry·1982
    Same author

    Antimalarials. 13. 5-Alkoxy analogues of 4-methylprimaquine.

    Journal of medicinal chemistry·1982
    Same journal

    Discovery of Effective Dual PROTAC Degraders with Synergistic Antitumor Activity for Overcoming Tamoxifen-Resistant Breast Cancer.

    Journal of medicinal chemistry·2026
    Same journal

    In Silico ADMET: From Current Practices to Novel Profilers.

    Journal of medicinal chemistry·2026
    Same journal

    A Zirconium Aza-BODIPY Derivative as a Near-Infrared Fluorescent/Photoacoustic Imaging Bimodal Probe.

    Journal of medicinal chemistry·2026
    Same journal

    Landscaping the Nitazene Scaffold to Identify Novel Mu-Opioid Receptor Modulators: From Molecular Design and Chemical Synthesis to Pharmacological Profiling.

    Journal of medicinal chemistry·2026
    Same journal

    Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

    Journal of medicinal chemistry·2026
    See all related articles

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Oncology

    Background:

    • Hydantoin derivatives are known for diverse biological activities.
    • Antitumor research is continuously seeking novel chemical scaffolds.
    • Structure-activity relationships guide the development of new anticancer agents.

    Purpose of the Study:

    • To synthesize and evaluate a series of novel hydantoin compounds as potential antitumor agents.
    • To investigate the impact of substituents at the 1, 3, and 5 positions on antitumor activity.
    • To identify lead compounds for further preclinical development.

    Main Methods:

    • Synthesis of 27 hydantoin derivatives with variations in substituents.
    • In vivo evaluation of antitumor activity using the P-388 lymphocytic leukemia mouse model.

    Related Experiment Videos

  • Determination of T/C (Tumor to Control) values to assess compound efficacy.

    • Main Results:

    • Several hydantoin compounds exhibited varying degrees of antitumor activity.
    • 5,5-bis(4-chlorophenyl)-1,3-dichlorohydantoin demonstrated the highest efficacy.
    • This lead compound achieved a T/C value of 190% against P-388 leukemia.

    Conclusions:

    • The synthesized hydantoins represent a promising class of potential anticancer drugs.
    • Substitution patterns, particularly at the 1 and 3 positions, significantly influence activity.
    • 5,5-bis(4-chlorophenyl)-1,3-dichlorohydantoin warrants further investigation as a novel antitumor candidate.